Federal grants to Genetobe Inc
Genetobe Inc in Ann Arbor, Michigan received $3.1 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Alcohol Research Programs, with $2.0 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$3.1 million
- Awards5
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $246,100 |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 3 | $1.6 million |
| FY 2025 | 0 | $0 |
Programs that fund Genetobe Inc
| Program | Awards | Amount |
|---|---|---|
| Alcohol Research Programs | 1 | $2.0 million |
| Biomedical Research and Research Training | 2 | $539,419 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $306,779 |
| Human Genome Research | 1 | $289,895 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $3.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A precision medicine for alcohol-associated liver disease - abstract the goal of this study is to develop an rnai-based genetic precision medicine to treat alcohol associated liver disease (AALD). Aald is a devastating health problem worldwide, accounts for the majority of alcohol-related mortality | Alcohol Research Programs | September 20, 2023 | $2.0 million |
| Novel selective SGLT-1 inhibitors for adjunctive therapy for cystic fibrosis associated metabolic diseases - project summary cf associated metabolic diseases including cf-associated liver disease (CFLD) and cf-related diabetes (CFRD) are leading extrapulmonary causes of mortality in cf. In 2019, the | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 6, 2024 | $306,779 |
| Developing novel type 1 crispr tools for gene editing therapy - abstract/project summary gene editing therapy using the nobel prize award-winning CRISPR-CAS9 technology promises a permanent cure for thousands of human diseases. Up to date, crispr tools have enabled dozens of fda-approved clinical tr | Biomedical Research and Research Training | February 15, 2024 | $293,319 |
| Genome editing therapy for usher syndrome type 3 - project summary/abstract usher syndrome type 3A (USH3A), an autosomal recessive disorder, is characterized by progressive loss of hearing and vision due to a CLARIN-1 (CLRN1) gene mutation. A person with type 3 usher syndrome will usually require co | Human Genome Research | August 31, 2023 | $289,895 |
| Development of MICAS9 mediated gene editing therapies for cystic fibrosis - project summary cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The disease affects multiple organs, with lung disease producing most cf m | Biomedical Research and Research Training | August 19, 2022 | $246,100 |
Questions people ask
How much federal grant money does Genetobe Inc get?
$3.1 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Genetobe Inc the most?
The Department of Health and Human Services, with $3.1 million in 5 awards.
What is Genetobe Inc's largest federal grant?
$2.0 million under Alcohol Research Programs, with its first action in the period on September 20, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Genetobe Inc?
Its largest are Alcohol Research Programs, Biomedical Research and Research Training and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Ann Arbor
- Regents of the University of Michigan
- National Center for Manufacturing Sciences Inc
- Ann Arbor Area Transportation Authority
- County of Washtenaw
- Washtenaw Community College
- Great Lakes Commission
- Great Lakes Fishery Commission
- Washtenaw Intermediate School District
Largest federal grant recipients in Michigan · Federal grants in Michigan